Catheter-based transarterial therapies for hepatocellular cancer

As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected. Catheter-based hepatic arterial procedures may be an option in patients with primary and metastatic liver c...

Full description

Saved in:

Bibliographic Details
Published in:	Cleveland Clinic journal of medicine Vol. 82; no. 12; pp. 828 - 834
Main Authors:	Laroia, Sandeep T, Morales, Steven A, Laroia, Archana T
Format:	Journal Article
Language:	English
Published:	United States 01-12-2015
Subjects:	Antineoplastic Agents - administration & dosage Carcinoma, Hepatocellular - blood supply Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic Cisplatin - administration & dosage Doxorubicin - administration & dosage Embolization, Therapeutic Humans Liver Neoplasms - blood supply Liver Neoplasms - therapy Mitomycin - administration & dosage Postoperative Care Postoperative Complications Radiotherapy Yttrium Radioisotopes - therapeutic use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected. Catheter-based hepatic arterial procedures may be an option in patients with primary and metastatic liver cancer. The authors describe four catheter-based hepatic arterial procedures and outline the management of potential complications during the immediate postprocedural period.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	0891-1150 1939-2869
DOI:	10.3949/ccjm.82a.14085